组学时代下机器学习方法在临床决策支持中的应用

doi:10.16288/j.yczz.18-139

遗传 ›› 2018, Vol. 40 ›› Issue (9): 693-703.doi: 10.16288/j.yczz.18-139

• 综述 • 下一篇

组学时代下机器学习方法在临床决策支持中的应用

赵学彤^1,²(),杨亚东^1,²,渠鸿竹^1,²,方向东^1,²()

^1. 中国科学院北京基因组研究所,中国科学院基因组科学与信息重点实验室,北京 100101
^2. 中国科学院大学,北京 100049

收稿日期:2018-05-17 修回日期:2018-07-23 出版日期:2018-09-20 发布日期:2018-07-30
作者简介:赵学彤,博士研究生,专业方向：复杂疾病多组学数据整合与解析。E-mail: zhaoxuetong@big.ac.cn
基金资助:
国家“精准医学研究”重点研发计划项目(2016YFC0901700);国家“精准医学研究”重点研发计划项目(2016YFC0901603);国家“精准医学研究”重点研发计划项目(2017YFC0907502);国家“精准医学研究”重点研发计划项目(2017YFC0908402);国家“精准医学研究”重点研发计划项目(2017YFC0907405)

Applications of machine learning in clinical decision support in the omic era

Zhao Xuetong^1,²(),Yang Yadong^1,²,Qu Hongzhu^1,²,Fang Xiangdong^1,²()

^1. CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China
^2. University of Chinese Academy of Sciences, Beijing 100049, China

Received:2018-05-17 Revised:2018-07-23 Online:2018-09-20 Published:2018-07-30
Supported by:
Supported by the National Key Research and Development Program of China(2016YFC0901700);Supported by the National Key Research and Development Program of China(2016YFC0901603);Supported by the National Key Research and Development Program of China(2017YFC0907502);Supported by the National Key Research and Development Program of China(2017YFC0908402);Supported by the National Key Research and Development Program of China(2017YFC0907405)

摘要/Abstract

摘要：

随着组学技术的不断发展,对于不同层次和类型的生物数据的获取方法日益成熟。在疾病诊治过程中会产生大量数据,通过机器学习等人工智能方法解析复杂、多维、多尺度的疾病大数据,构建临床决策支持工具,辅助医生寻找快速且有效的疾病诊疗方案是非常必要的。在此过程中,机器学习等人工智能方法的选择显得尤为重要。基于此,本文首先从类型和算法角度对临床决策支持领域中常用的机器学习等方法进行简要综述,分别介绍了支持向量机、逻辑回归、聚类算法、Bagging、随机森林和深度学习,对机器学习等方法在临床决策支持中的应用做了相应总结和分类,并对它们的优势和不足分别进行讨论和阐述,为临床决策支持中机器学习等人工智能方法的选择提供有效参考。

关键词: 疾病, 机器学习, 人工智能, 临床决策支持

Abstract:

With the development of the omic technologies, the acquisition approaches of various biological data on different levels and types are becoming more mature. As a large amount of data will be produced in the process of diagnosis and treatment of diseases, it is necessary to utilize the artificial intelligence such as machine learning to analyze complex, multi-dimensional and multi-scale data and to construct clinical decision support tools. It will provide a method to figure out rapid and effective programs in diagnosis and treatment. In this process, the choice of artificial intelligence seems to be particularly important, such as machine learning. The article reviews the type and algorithm of machine learning used in clinical decision support, such as support vector machines, logistic regression, clustering algorithms, Bagging, random forests and deep learning. The application of machine learning and other methods in clinical decision support has been summarized and classified. The advantages and disadvantages of machine learning are elaborated. It will provide a reference for the selection between machine learning and other artificial intelligence methods in clinical decision support.

Key words: diseases, machine learning, artificial intelligence, clinical decision support

赵学彤, 杨亚东, 渠鸿竹, 方向东. 组学时代下机器学习方法在临床决策支持中的应用[J]. 遗传, 2018, 40(9): 693-703.

Zhao Xuetong, Yang Yadong, Qu Hongzhu, Fang Xiangdong. Applications of machine learning in clinical decision support in the omic era[J]. Hereditas(Beijing), 2018, 40(9): 693-703.

参考文献

[1]	Qu HZ, Fang XD . A brief review on the human encyclopedia of DNA Elements (ENCODE) project. Genomics Prot Bioinform, 2013,11(3):135-141.
[2]	Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Peltonen L, Dermitzakis E, Bonnen PE, Altshuler DM, Gibbs RA, de Bakker PI, Deloukas P, Gabriel SB, Gwilliam R, Hunt S, Inouye M, Jia X, Palotie A, Parkin M, Whittaker P, Yu F, Chang K, Hawes A, Lewis LR, Ren Y, Wheeler D, Gibbs RA, Muzny DM, Barnes C, Darvishi K, Hurles M, Korn JM, Kristiansson K, Lee C, McCarrol SA, Nemesh J, Dermitzakis E, Keinan A, Montgomery SB, Pollack S, Price AL, Soranzo N, Bonnen PE, Gibbs RA, Gonzaga-Jauregui C, Keinan A, Price AL, Yu F, Anttila V, Brodeur W, Daly MJ, Leslie S, McVean G, Moutsianas L, Nguyen H, Schaffner SF, Zhang Q, Ghori MJ, McGinnis R, McLaren W, Pollack S, Price AL, Schaffner SF, Takeuchi F, Grossman SR, Shlyakhter I, Hostetter EB, Sabeti PC, Adebamowo CA, Foster MW, Gordon DR, Licinio J, Manca MC, Marshall PA, Matsuda I, Ngare D, Wang VO, Reddy D, Rotimi CN, Royal CD, Sharp RR, Zeng C, Brooks LD, McEwen JE . Integrating common and rare genetic variation in diverse human populations. Nature, 2010,467(7311):52-58.
[3]	Xie BB, Yang YD, Ding N, Fang XD . Identification of disease targets for precision medicine by integrative analysis of multi-omics data. Hereditas (Beijing), 2015,37(7):655-663.
[3]	谢兵兵, 杨亚东, 丁楠, 方向东 . 整合分析多组学数据筛选疾病靶点的精准医学策略. 遗传, 2015,37(7):655-663.
[4]	Goldberg Y . A primer on neural network models for natural language processing. Comput Sci, 2015, .
[5]	Szeliski R . Computer vision : algorithms and applications. Heidelberg: Springer-Verlag Berlin, 2010.
[6]	Russell SJ, Norvig PN . Artificial intelligence: A modern approach. Prentice Hall. Appl Mech Mater, 1995,263(5):2829-2833.
[7]	Kim YS, Street WN, Menczer F . Evolutionary model selection in unsupervised learning. Intell Data Anal, 2002,6(6):531-556.
[8]	Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR . Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA, 2001,98(26):15149-15154.
[9]	Zhang T, Yang YD, Fang XD . Transcriptome alternative splicing analysis applied to precision medical research. J Dev Med, 2016,4(2):78-84.
[9]	张韬, 杨亚东, 方向东 . 应用于精准医学研究的转录组可变剪接分析. 发育医学电子杂志, 2016,4(2):78-84.
[10]	Li P, He N, Li YM, Fang XD . Progress in single cell transcriptome analysis and developmental biology. J Dev Med, 2017,5(1):28-34.
[10]	李品, 贺宁, 李艳明, 方向东 . 单细胞转录组数据分析与发育生物学研究进展. 发育医学电子杂志, 2017,5(1):28-34.
[11]	Chun H, Kele? S . Sparse partial least squares regression for simultaneous dimension reduction and variable selection. J R Stat Soc Series B Stat Methodol, 2010,72(1):3-25.
[12]	Isabelle G, André E . An introduction to variable and feature selection. J Mach Learn Res, 2003,3(7-8):1157-1182.
[13]	Awada W, Khoshgoftaar TM, Dittman D, Wald R, Napolitano A . A review of the stability of feature selection techniques for bioinformatics data. Proceedings of the 2012 IEEE 13th International Conference on Information Reuse and Integration, IRI 2012,2012:356-363.
[14]	Saeys Y, Inza I, Larra?aga P . A review of feature selection techniques in bioinformatics. Bioinformatics, 2007,23(19):2507-2517.
[15]	Jiang Y, Shi X, Zhao Q, Krauthammer M, Rothberg BEG, Ma S . Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis. Genomics, 2016,107(6):223-230.
[16]	Ma S, Huang J . Penalized feature selection and classification in bioinformatics. Brief Bioinform, 2008,9(5):392-403.
[17]	Fogarty J, Baker RS, Hudson SE . Case studies in the use of ROC curve analysis for sensor-based estimates in human computer interaction. In Proceedings of Graphics Interface, 2005.
[18]	Raykar V, Steck H, Krishnapuram B, Dehing-Oberije C, Lambin P . On ranking in survival analysis: bounds on the concordance index. Adv Neural Inform Proc Sys, 20:1209-1216.
[19]	Cortes C, Vapnik V . Support-vector networks. Mach Learn, 1995,20(3):273-297.
[20]	Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D . Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics, 2000,16(10):906-914.
[21]	Best Myron G, Sol N, Kooi I, Tannous J, Westerman Bart A, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit Egbert F, Verheul Henk M, Noske David P, Reijneveld Jaap C, Nilsson RJonas A, Tannous Bakhos A, Wesseling P, Wurdinger T . RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Canc Cell, 2015,28(5):666-676.
[22]	Narasimhan H, Agarwal S . SVM pAUC tight: a new support vector method for optimizing partial AUC based on a tight convex upper bound. Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD), 2013: 167-175.
[23]	Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu GK, Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S, Sengupta S, Sundaram M, Majumder PK . Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun, 2015,6:6169.
[24]	Han L, Yuan Y, Zheng S, Yang Y, Li J, Edgerton ME, Diao L, Xu Y, Verhaak RGW, Liang H . The Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun, 2014,5:3963.
[25]	Paik ES, Choi HJ, Kim TJ, Lee JW, Kim BG, Bae DS, Choi CH . Molecular signature for lymphatic invasion associated with survival of epithelial ovarian cancer. Cancer Res and Treat, 2017,50(2):461-473.
[26]	Cai X, Han X, Zhang S, Luo Y, Chen Y, Ji L . Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese. PLoS One, 2014,9(3):e91174.
[27]	Best MG, Sol N, In ‘t Veld SGJG, Vancura A, Muller M, Niemeijer A-LN, Fejes AV, Tjon Kon Fat L-A, Huis In ‘t Veld AE, Leurs C, Le Large TY, Meijer LL, Kooi IE, Rustenburg F, Schellen P, Verschueren H, Post E, Wedekind LE, Bracht J, Esenkbrink M, Wils L, Favaro F, Schoonhoven JD, Tannous J, Meijers-Heijboer H, Kazemier G, Giovannetti E, Reijneveld JC, Idema S, Killestein J, Heger M, de Jager SC, Urbanus RT, Hoefer IE, Pasterkamp G, Mannhalter C, Gomez-Arroyo J, Bogaard H-J, Noske DP, Vandertop WP, van den Broek D, Ylstra B, Nilsson RJA, Wesseling P, Karachaliou N, Rosell R, Lee-Lewandrowski E, Lewandrowski KB, Tannous BA, de Langen AJ, Smit EF, van den Heuvel MM, Wurdinger T . Swarm intelligence-enhanced detection of non-small- cell lung cancer using tumor-educated platelets. Cancer Cell, 2017, 32(2): 238- 252.e9.
[28]	Yu ZW, Chen HT, You J, Liu JM, Wong HS, Han G, Li L . Adaptive fuzzy consensus clustering framework for clustering analysis of cancer data. IEEE/ACM Trans Comput Biol Bioinform, 2015,12(4):887-901.
[29]	Mahata P . Exploratory consensus of hierarchical clusterings for melanoma and breast cancer. IEEE/ACM Trans Comput Biol Bioinform, 2010,7(1):138-152.
[30]	Wahdan P, Saad A, Shoukry A . Automated breast tumour detection in ultrasound images using support vector machine and ensemble classification. J Biomed Eng Biosci, 2016,3.
[31]	Xu RH, Wei W, Krawczyk M, Wang W, Luo H, Flagg K, Yi S, Shi W, Quan Q, Li K, Zheng L, Zhang H, Caughey BA, Zhao Q, Hou J, Zhang R, Xu Y, Cai H, Li G, Hou R, Zhong Z, Lin D, Fu X, Zhu J, Duan Y, Yu M, Ying B, Zhang W, Wang J, Zhang E, Zhang C, Li O, Guo R, Carter H, Zhu JK, Hao X, Zhang K . Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat Mater, 2017,16(11):1155-1161.
[32]	Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, Zhang D, Su Z, Fang Z, Lan Z, Li J, Xiao L, Li J, Li R, Li X, Li F, Ren H, Huang Y, Peng Y, Li G, Wen B, Dong B, Chen JY, Geng QS, Zhang ZW, Yang H, Wang J, Wang J, Zhang X, Madsen L, Brix S, Ning G, Xu X, Liu X, Hou Y, Jia H, He K, Kristiansen K . The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun, 2017,8(1):845.
[33]	Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S . Corrigendum: Dermatologist-level classification of skin cancer with deep neural networks. Nature, 2017,542(7660):686.
[34]	Kooi T, Litjens G, Van GB, Gubern-Mérida A, Sánchez CI, Mann R, den HA, Karssemeijer N . Large scale deep learning for computer aided detection of mammographic lesions. Med Image Anal, 2017,35:303-312.
[35]	Liu Y, Gadepalli K, Norouzi M, Dahl GE, Kohlberger T, Boyko A, Venugopalan S, Timofeev A, Nelson PQ, Corrado GS, Hipp JD, Peng LL, Stumpe MC . Detecting cancer metastases on gigapixel pathology images. 2017, .
[36]	Shen W, Zhou M, Yang F, Yang C, Tian J . Multi-scale convolutional neural networks for lung nodule classification. Inf Process Med Imaging, 2015,24:588-599.
[37]	Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature, 2014,511(7511):543-550.
[38]	Marinelli RJ, Montgomery K, Liu CL, Shah NH, Prapong W, Nitzberg M, Zachariah ZK, Sherlock GJ, Natkunam Y, West RB, van de Rijn M, Brown PO, Ball CA . The stanford tissue microarray database. Nucleic Acids Research, 2008,36(Database issue):D871-D877.
[39]	Yu KH, Zhang C, Berry GJ, Altman RB, Ré C, Rubin DL, Snyder M . Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun, 2016,7:12474.
[40]	Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A . Conditional variable importance for random forests. BMC Bioinf, 2008,9:307.
[41]	Diaz-Uriarte R . GeneSrF and varSelRF: a web-based tool and R package for gene selection and classification using random forest. BMC Bioinf, 2007,8(1):328.
[42]	EKrishna SM, Moxon JV, Golledge J . A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci, 2015,16(5):11294-22322.
[43]	Haiser HJ, Gootenberg DB, Chatman K, Sirasani G, Balskus EP, Turnbaugh PJ . Predicting and manipulating cardiac drug inactivation by the human gut bacterium eggerthella lenta. Science, 2014,341(6143):295-298.
[44]	Charalampous K, Gasteratos A . On-line deep learning method for action recognition. Patt Anal Appl, 2016,19(2):337-354.
[45]	Dou Q, Chen H, Yu L, Zhao L, Qin J, Wang D, Mok V, Shi L, Heng PA . Automatic detection of cerebral microbleeds from MR images via 3D convolutional neural networks. IEEE Trans Med Imaging, 2016,35(5):1182-1195.
[46]	Riccardo M, Li L, Kidd BA, Dudley JT . Deep Patient: An unsupervised representation to predict the future of patients from the electronic health records. Sci Rep, 2016,6:26094.
[47]	S Somashekhar S P, Kumar R, Kumar A, Patil P, Rauthan A . 551PD validation study to assess performance of IBM cognitive computing system Watson for oncology with manipal multidisciplinary tumour board for 1000 consecutive cases: An Indian experience. Annal Oncol, 2016, 27(suppl 9), .
[48]	Herath DH, Wilsoning D, Ramos E, Morstyn G . Assessing the natural language processing capabilities of IBM Watson for oncology using real australian lung cancer cases. 2016.
[49]	Somashekhar SP, Sepúlveda MJ, Puglielli S, Norden AD, Shortliffe EH, Rohit CK, Rauthan A, Arun NK, Patil P, Rhee K, Ramya Y . Watson for oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol, 2018,29(2):418-423.
[50]	van der Heijden AA, Abramoff MD, Verbraak F, Van MH, Liem A, Nijpels G . Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol, 2018,96(1):63-68.
[51]	Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, Mark DB, Marwick TH, McCallister BD, Thompson PD, Winters WL, Yanowitz FG, Ritchie JL, Gibbons RJ, Cheitlin MD, Eagle KA, Gardner TJ, Garson A, Lewis RP, O'Rourke RA, Ryan TJ . ACC/AHA Guidelines for Exercise Testing. A report of the American college of cardiology/American heart association task force on practice guidelines (committee on exercise testing). J Am Coll Cardiol, 1997,30(1):260-311.
[52]	Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TA, Yanovski SZ, Kendall KA, Morgan LC, Trisolini MG, Velasco G, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF . 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines. Journal of the American College of Cardiology, 2014,63(25):2960-2984.
[53]	Weng SF, Reps J, Kai J, Garibaldi JM, Qureshi N . Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS One, 2017,12(4):e0174944.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

组学时代下机器学习方法在临床决策支持中的应用

Applications of machine learning in clinical decision support in the omic era

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	姜义圣,许执恒. 脑发育疾病及发病机制[J]. 遗传, 2019, 41(9): 801-815.
[2]	孙兆庆, 闫波. 转录因子GATA6在心血管疾病中的作用及其调控机制[J]. 遗传, 2019, 41(5): 375-383.
[3]	张桂珊, 杨勇, 张灵敏, 戴宪华. 机器学习方法在CRISPR/Cas9系统中的应用[J]. 遗传, 2018, 40(9): 704-723.
[4]	黄耀强,李国玲,杨化强,吴珍芳. 基因编辑猪在生物医学研究中的应用[J]. 遗传, 2018, 40(8): 632-646.
[5]	彭哲也,唐紫珺,谢民主. 机器学习方法在基因交互作用探测中的研究进展[J]. 遗传, 2018, 40(3): 218-226.
[6]	朱亚男, 敖英, 李斌, 万阳, 汪晖. 足细胞发育异常及相关肾脏疾病研究进展[J]. 遗传, 2018, 40(2): 116-125.
[7]	黎伟, 秦俊, 汪晖, 陈廖斌. 表观遗传生物标志物在人类疾病早期诊治中的研究进展[J]. 遗传, 2018, 40(2): 104-115.
[8]	陈一欧, 宝颖, 马华峥, 伊宗裔, 周卓, 魏文胜. 基因编辑技术及其在中国的研究发展[J]. 遗传, 2018, 40(10): 900-915.
[9]	王永煜,余薇,周斌. Hippo信号通路与心血管发育及疾病调控[J]. 遗传, 2017, 39(7): 576-587.
[10]	周欣,李伟芸,王红艳. MST1/2调控先天免疫的功能和机制[J]. 遗传, 2017, 39(7): 642-649.
[11]	李爽,杨圆圆,邱艳,陈彦好,徐璐薇,丁秋蓉. 基因组编辑技术在精准医学中的应用[J]. 遗传, 2017, 39(3): 177-188.
[12]	王建, 张凯翔, 芦国珍, 赵湘辉. 5-羟甲基胞嘧啶及其TET氧合酶在神经系统发育和相关疾病中的研究进展[J]. 遗传, 2017, 39(12): 1138-1149.
[13]	何一旻, 顾鸣敏. 肌球蛋白重链基因在人类遗传性疾病中的研究进展[J]. 遗传, 2017, 39(10): 877-887.
[14]	孙吉吉, 赵晓旭, 乔丽华, 梅霜, 聂志鹏, 张青海, 冀延春, 蒋萍萍, 管敏鑫. 线粒体遗传疾病细胞模型的构建：永生淋巴细胞系和转线粒体细胞系[J]. 遗传, 2016, 38(7): 666-673.
[15]	刘芳, 宋小珍, 谢华, 陈晓丽. 体细胞变异对神经系统常见肿瘤和发育异常类疾病的致病性[J]. 遗传, 2016, 38(3): 196-205.